EP3243957

ERMONT
Application Number
EP17170410A
Filing Date
May 10, 2017
Status
Patent Maintained As Amended
Nov 12, 2021
Grant Date
Dec 15, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3243957B2 was granted on Dec 15, 2021 by Ermont The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AMMANN SCHWEIZ AGSep 4, 2019 N.A.

The table below shows the patents of Ermont that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3107556Compositions For Preventing And/Or Treating Pathological Conditions Associated With Alpha-GlucosidaseApr 10, 20192